Menorrhagia. A symposium.
D000293:Adolescent; D000328:Adult; D000614:Aminocaproates / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000150:complications; D004107:Dilatation and Curettage; D004412:Dysmenorrhea / Q000150:complications; D005260:Female; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007044:Hysterectomy; D008595:Menorrhagia / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D008598:Menstruation / Q000187:drug effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000503:physiopathology; D011374:Progesterone / Q000494:pharmacology; D013246:Sterilization, Tubal / Q000009:adverse effects; D014594:Uterine Neoplasms / Q000175:diagnosis; D014599:Uterus / Q000503:physiopathology
D000614:Aminocaproates; D000893:Anti-Inflammatory Agents; D000933:Antifibrinolytic Agents; D006454:Hemoglobins; D011374:Progesterone; D001241:Aspirin